|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06826 HAOHAI BIOTEC
Nominal 
16.730 +0.229 (+1.388%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 490,973 | 648,572 | 634,450 | 231,296 |
| Net Cash from / (used in) Investing Activities | -- | 200,548 | 282,279 | (376,650) | (681,815) |
| Net Cash from / (used in) Financing Activities | -- | (580,659) | (390,345) | (257,727) | (288,350) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 110,862 | 540,506 | 73 | (738,869) |
| Cash & Cash Equivalents at beginning of period | -- | 1,112,905 | 569,318 | 559,197 | 1,283,893 |
| Effect of Foreign Exchange Rate Changes | -- | 4,631 | 3,081 | 10,048 | 14,173 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 1,228,398 | 1,112,905 | 569,318 | 559,197 |
| Remarks: | Real time quote last updated: 04/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 112,627 |
| %Change | -46.639% |
| EPS / (LPS) | RMB 0.490 |
| NBV Per Share (¥) | RMB 23.571 |